NIO's Q4 deliveries fell short of expectations, highlighting sluggish growth in the competitive Chinese market. See why I'm ...

Organovo Holdings, Inc. (ONVO), a clinical-stage biotech firm focused on advancing innovative treatments for inflammatory bowel ...

Nio has been expanding its brand portfolio to help it address larger segments of the market and cater to more niche needs.

Dec. 11, 2024 — Investigators who previously found that a daily statin pill helps prevent heart attacks and strokes in people with HIV have now discovered a potential mechanism that may help to ...

We recently published a list of the 12 Best Long-Term Penny Stocks to Buy According to Hedge Funds. In this article, we are ...

Development items topped the list for the Town Board in December. At its meeting, the board approved a resolution to act as ...

NIO Inc.'s December delivery results and potential impact of EV subsidies on company's profitability and competitive edge in ...

A long-delayed travel plaza is finally scheduled to be constructed on Business Route 15 in Richmond Township according to a ...

However, putting your money to work on Wall Street is all about looking to the future and not reflecting too much on the past. Regardless of whether the bull market extends for a third year or the ...

Chinese electric vehicle makers including Nio and Li Auto have followed market leaders Tesla and BYD in extending buying ...

Organovo Holdings ( (ONVO) ) has issued an announcement.

StockNews.com initiated coverage on shares of Organovo (NASDAQ:ONVO – Free Report) in a research note issued to investors on Sunday morning. The brokerage issued a sell rating on the medical research ...